CORD-19:775b90287b44353bee979abb0970a4666022f86d / 776926-777070 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"T97051","span":{"begin":0,"end":144},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The most frequently reported adverse events with the 0.10% formulation were epistaxis (4.8%), dysgeusia (2.4%), URI (2.4%), and sneezing (1.8%)."}

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T407","span":{"begin":0,"end":144},"obj":"Sentence"}],"text":"The most frequently reported adverse events with the 0.10% formulation were epistaxis (4.8%), dysgeusia (2.4%), URI (2.4%), and sneezing (1.8%)."}

    CORD-19-PD-MONDO

    {"project":"CORD-19-PD-MONDO","denotations":[{"id":"T5814","span":{"begin":76,"end":85},"obj":"Disease"},{"id":"T38890","span":{"begin":76,"end":85},"obj":"Disease"}],"attributes":[{"id":"A5814","pred":"mondo_id","subj":"T5814","obj":"http://purl.obolibrary.org/obo/MONDO_0005305"},{"id":"A84948","pred":"mondo_id","subj":"T38890","obj":"http://purl.obolibrary.org/obo/MONDO_0005305"}],"text":"The most frequently reported adverse events with the 0.10% formulation were epistaxis (4.8%), dysgeusia (2.4%), URI (2.4%), and sneezing (1.8%)."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T4063","span":{"begin":76,"end":85},"obj":"Phenotype"},{"id":"T4064","span":{"begin":94,"end":103},"obj":"Phenotype"}],"attributes":[{"id":"A4063","pred":"hp_id","subj":"T4063","obj":"http://purl.obolibrary.org/obo/HP_0000421"},{"id":"A4064","pred":"hp_id","subj":"T4064","obj":"http://purl.obolibrary.org/obo/HP_0031249"}],"text":"The most frequently reported adverse events with the 0.10% formulation were epistaxis (4.8%), dysgeusia (2.4%), URI (2.4%), and sneezing (1.8%)."}